Hepatoma II.
D000970:Antineoplastic Agents / Q000008:administration & dosage; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D011379:Prognosis
D000970:Antineoplastic Agents